These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6245422)

  • 41. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin.
    Eide PK; Hole K
    Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
    Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
    J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence against adrenergic motor transmission in the guinea-pig vas deferens.
    Ambache N; Zar MA
    J Physiol; 1971 Jul; 216(2):359-89. PubMed ID: 4397760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse.
    Singleton C; Marsden CA
    Psychopharmacology (Berl); 1981; 74(2):173-6. PubMed ID: 6168003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of intracerebroventricular injection of 5,6-dihydroxytryptamine and 6-hydroxydopamine on supra-ependymal nerves.
    Lorez HP; Richards JG
    Brain Res; 1976 Oct; 116(1):165-71. PubMed ID: 974766
    [No Abstract]   [Full Text] [Related]  

  • 46. Dopamine-induced amylase secretion from guinea-pig submandibular gland.
    Bloom GD; Carlsöö B; Danielsson A
    Br J Pharmacol; 1975 Aug; 54(4):523-8. PubMed ID: 169937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor.
    Vetulani J; Reichenberg K; Wiszniowska G; Marchaj J
    Pol J Pharmacol Pharm; 1977; 29(6):645-56. PubMed ID: 564059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.
    Claassen V; Davies JE; Hertting G; Placheta P
    Br J Pharmacol; 1977 Aug; 60(4):505-16. PubMed ID: 302726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings].
    Waddington JL; Crow TJ
    Br J Pharmacol; 1977 Mar; 59(3):465P-466P. PubMed ID: 300261
    [No Abstract]   [Full Text] [Related]  

  • 50. Pre- and postsynaptic effects of p-tyramine and p-octopamine in the prostatic portion of the rat vas deferens.
    Celuch SM; Juorio AV
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):39-46. PubMed ID: 2907098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of acute cocaine administration on the DOI-induced head-twitch response in reserpinized mice.
    Darmani NA
    Pharmacol Biochem Behav; 1994 Sep; 49(1):229-32. PubMed ID: 7816879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effects of various serotonin releasing agents in mice.
    Hwang EC; Van Woert MH
    Biochem Pharmacol; 1980 Dec; 29(23):3163-7. PubMed ID: 6449931
    [No Abstract]   [Full Text] [Related]  

  • 54. Release of dopamine, noradrenaline and dopamine B-hydroxylase from mouse neuroblastoma.
    Fraeyman NH; De Smet FH; Van de Velde EJ; Moerman EJ; De Schaepdryver AF
    Life Sci; 1984 Aug; 35(6):619-29. PubMed ID: 6431216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Head twitches produced by serotonergic drugs and opiates after lesion of the mesostriatal serotonergic system of the rat.
    Vetulani J; Byrska B; Reichenberg K
    Pol J Pharmacol Pharm; 1979; 31(4):413-23. PubMed ID: 316525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nature of salivation produced by thyrotropin-releasing hormone (TRH).
    Beleslin DB; Jovanovic-Micic D; Tomic-Beleslin N
    Brain Res Bull; 1987 Mar; 18(3):463-5. PubMed ID: 3107760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of drug-induced rotation in rats lesioned in the medial forebrain bundle with 5,6-dihydroxytryptamine or 6-hydroxydopamine.
    Pieri M; Pieri L; Saner A; Da Prada M; Haefely W
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):118-30. PubMed ID: 127559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Head-twitches induced by p-hydroxyamphetamine in mice.
    Tadano T; Satoh S; Kisara K
    Jpn J Pharmacol; 1986 Aug; 41(4):519-23. PubMed ID: 3022049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-Methyl-D-aspartate receptor antagonists enhance the head-twitch response, a 5-hydroxytryptamine2 receptor-mediated behaviour, in reserpine-treated mice.
    Kim HS; Park IS; Lim HK; Choi HS; Oh S; Park WK; Jang CG; Kim SH; Chang MJ
    J Pharm Pharmacol; 2000 Jun; 52(6):717-22. PubMed ID: 10875549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.